The Hepatitis C Virus Genotype 3a S310 Strain Permits Claudin‐1–Independent Entry
Microbiology and Immunology · 2025
DOI: 10.1111/1348-0421.70013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology and Immunology, 2025. Verfasst von Ryosuke Suzuki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology II, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan. Hauptthemen laut MEDLINE: Hepacivirus, Virus Internalization, Claudin-1, Receptors, Virus. Die Arbeit nennt 46 Literaturangaben. Gefördert von: This study was supported, in part, by grants-in-aid from the Japan Agency for Medical Research and Development: grant numbers JP19fk0310120 (RS), JP22fk0210109….
Abstract (Originalsprache)
We investigated the receptor usage of the hepatitis C virus (HCV) genotype 3a S310 strain using cell culture–derived HCV (HCVcc) and trans‐complemented HCV particles (HCVtcp). Infection by HCV strains of genotypes 1, 2, and 3 was inhibited by anti‐CD81 antibody. By contrast, anti–claudin (CLDN)1 antibody reduced infection by the genotype 1b TH strain and genotype 2a JFH‐1 strain but had no effect on the S310 strain (genotype 3a). Moreover, CLDN1‐knockout cells remained permissive to infection with a chimeric HCVcc bearing the S310 envelope in a JFH‐1 backbone. In CLDN1‐deficient cells, infection by HCVtcp derived from the S310 strain was significantly reduced by treatment with anti–claudin‐6 (CLDN6) antibody or knockdown of CLDN6 mRNA, suggesting that the S310 strain utilizes CLDN6 as an alternate entry factor. Further analyses revealed that HCVtcp of genotype 4a (ED43 strain) and genotype 6a (HK6a strain) also infected CLDN1‐deficient cells. These findings provide new insights into CLDN usage by diverse HCV genotypes and raise the possibility that CLDN tropism may affect viral entry, infection efficiency, and pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Virology II, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
- Department of Biological Science and Technology, Tokyo University of Science, Tokyo, Japan.
- Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
- Department of Virology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
- Center for Infectious Disease Education and Research (CiDER), The University of Osaka, Osaka, Japan.
- Research, Institute for Microbial Diseases (RIMD), The University of Osaka, Osaka, Japan.
ORCID-Profile: Ryosuke Suzuki, Masamichi Muramatsu
Förderung
- This study was supported, in part, by grants-in-aid from the Japan Agency for Medical Research and Development: grant numbers JP19fk0310120 (RS), JP22fk0210109…
Zitieren
APA
Suzuki, R., Yato, K., Tosaka, T., Matsuda, M., Hmwe, S. S., Fukasawa, M., Fukuhara, T., Matsuura, Y., Muramatsu, M., & Wakita, T. (2025). The Hepatitis C Virus Genotype 3a S310 Strain Permits Claudin‐1–Independent Entry. Microbiology and Immunology. https://doi.org/10.1111/1348-0421.70013
Vancouver
Suzuki R, Yato K, Tosaka T, Matsuda M, Hmwe SS, Fukasawa M, et al. The Hepatitis C Virus Genotype 3a S310 Strain Permits Claudin‐1–Independent Entry. Microbiology and Immunology. 2025. doi:10.1111/1348-0421.70013
BibTeX
@article{Suzuki2025,
author = {Suzuki, Ryosuke and Yato, Keigo and Tosaka, Takashi and Matsuda, Mami and Hmwe, Su Su and Fukasawa, Masayoshi and Fukuhara, Takasuke and Matsuura, Yoshiharu and Muramatsu, Masamichi and Wakita, Takaji},
title = {The Hepatitis C Virus Genotype 3a S310 Strain Permits Claudin‐1–Independent Entry},
journal = {Microbiology and Immunology},
year = {2025},
doi = {10.1111/1348-0421.70013}
}
EUVIMED